Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Pharmaceutical Preparations (2)
- Pharmaceutics and Drug Design (2)
- Pharmacy and Pharmaceutical Sciences (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
-
- Animal Structures (1)
- Biochemical and Biomolecular Engineering (1)
- Biomaterials (1)
- Biomechanics and Biotransport (1)
- Biomedical Engineering and Bioengineering (1)
- Biomedical and Dental Materials (1)
- Chemical Engineering (1)
- Diseases (1)
- Engineering (1)
- Inorganic Chemicals (1)
- Lipids (1)
- Macromolecular Substances (1)
- Molecular, Cellular, and Tissue Engineering (1)
- Nanoscience and Nanotechnology (1)
- Neoplasms (1)
- Nervous System (1)
- Nucleic Acids, Nucleotides, and Nucleosides (1)
- Other Biomedical Engineering and Bioengineering (1)
- Therapeutics (1)
- Keyword
-
- 1242 (1)
- Brain tumor (1)
- CRISPR (1)
- Fluorescent imaging (1)
- Glioma (1)
-
- IVIS Imaging (1)
- Intraperitoneal Delivery (1)
- Iodine nanoparticles (1)
- Lipid nanoparticles (1)
- Localization (1)
- Mesoporous Silica Nanoparticles (1)
- Microfluidics (1)
- Nanoparticle localization (1)
- Nanotechnology (1)
- Novel nanoparticles (1)
- Ovarian Cancer (1)
- Peritoneal Metastasis (1)
- RNA therapeutics (1)
- SiRNA (1)
- Targeted Drug Delivery (1)
- Tumor Spheroids (1)
Articles 1 - 3 of 3
Full-Text Articles in Nanomedicine
Fluorescent Labeling And Size-Dependent Uptake Of Mesoporous Silica Nanoparticles In Ovarian Cancer Tumor Spheroids, Kimberly R. Berardis
Fluorescent Labeling And Size-Dependent Uptake Of Mesoporous Silica Nanoparticles In Ovarian Cancer Tumor Spheroids, Kimberly R. Berardis
Honors Scholar Theses
Ovarian cancer is the most lethal gynecologic malignancy, with most patients presenting at an advanced stage. While surgical debulking improves survival, nonresectable tumors (<1 cm) contribute significantly to morbidity and remain difficult to treat. Nanocarrier-based drug delivery systems offer an innovative approach to targeted therapy and palliation. In vivo models have demonstrated that intraperitoneally delivered mesoporous silica nanoparticles (MSNs) preferentially accumulate in tumors with low systemic exposure, enabling targeted chemo- and radiotherapy.
MSNs are particularly suited for radiotherapeutic delivery, as their strong interactions with tumor extracellular matrices drive selective uptake. Additionally, they exhibit excellent stability under neutron flux, allowing for loading with stable isotopes and irradiation immediately prior to administration. High radionuclide retention after dilution further minimizes systemic exposure and toxicity.
A key …
A Robust Delivery System For Rna Therapeutics, Suleyman Bozal
A Robust Delivery System For Rna Therapeutics, Suleyman Bozal
Honors Scholar Theses
The field of RNA therapeutics is currently undergoing both transformation and expansion. Specifically, research in lipid nanoparticle (LNP) based RNA therapeutics is gaining significant traction. Other research into mechanisms of gene regulation and manipulation, including siRNA and the CRISPR/Cas9 system have demonstrated the potential of RNA-based disease treatment. This work identifies a delivery system which can regulate expression of green fluorescent protein (GFP) in human embryonic kidney cells (HEK293) stably expressing GFP.
Analysis of siRNA-induced gene knockdown demonstrates that the current siRNA-LNP formulation is equally as effective as a commercially available transfection reagent, Lipofectamine RNAiMAX (RNAiMAX), which is designed specifically …
Distribution And Localization Of Novel Iodine Nanoparticles In The Human Glioma 1242 Growing In The Brains Of Mice, Benjamin Billings
Distribution And Localization Of Novel Iodine Nanoparticles In The Human Glioma 1242 Growing In The Brains Of Mice, Benjamin Billings
Honors Scholar Theses
Observing and designing the in vivo distribution and localization of therapeutic nanoparticles is an essential aspect of developing and understanding novel nanoparticle- based medical treatments. This study investigates novel PEGylated Iodine-based nanoparticles (INPs), an alternate composition to the more widely researched gold nanoparticles (AuNPs), which may help avoid adverse effects associated with AuNPs, such as potential toxicity and skin discoloration, when used in similar applications. Determining the localization of the novel INPs within murine brains containing human glioma U-1242MG cells is critical in assisting the development of radiation dose enhancement therapy for this aggressive cancer. Radiation dose enhancement utilizes the …